Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical passes the values gate
Price2.07 USD
Fair value1.49
Ethical score70.0/100
Value readOvervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-07-02Read Accumulation2.04+1.5% to today ✓First review on file: Accumulation
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Olaplex Holdings, Inc. holds its Accumulation at $2.07. Elevated stress, defensive posture warranted, held for 24 days.
As held on the ledger · 2026-11-05
Phase
Accumulation
Quantitative state
Elevated stress, defensive posture warranted, held for 24 days
Price at the screen
$2.07
Valuation
N/A trailing · 20.28 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.84
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
23.53%
Below 33%
Interest-bearing debt is just 23.5% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
23.22%
Below 49%
Money owed to the company is 23.2% of assets, under the 49% limit.
Pass
Revenue purity
3.51%
Below 5%
Only 3.5% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Olaplex Holdings, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 24%, inside the ~33% line, and interest is about 4% of its income, under the ~5% line, so it passes.
Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when OLPX's ethical verdict changes
Today OLPX passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 5 Nov 2026: it trades above our $1.49 fair value estimate, 2.50% revenue growth.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. The price runs 38.9% above the base estimate.
Where our models see it going: fair-value estimate $1.49, with a range of $1.49 to $1.71, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Haircare Brand Loses Shine Amid Flat Sales
Picture a salon shelf once stocked with miracle treatments now gathering dust as customers switch to cheaper alternatives. Olaplex shows revenue growth stuck at just 2 percent and a profit margin of minus 4 percent, leaving return on equity negative at 2 percent. The shares trade at 20.3 times forward earnings while our fair value sits 28 percent lower, so we pass.
The business sells specialist shampoos and conditioners that once rode post-pandemic demand, yet nothing in the numbers suggests a durable edge or reacceleration. An ethical screen clears the company, yet that alone does not create an investment case when growth has stalled and margins remain negative.
Cyclical retail demand can swing quickly, and unknown competitive pressure adds further uncertainty around any recovery. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
OLPX trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-02Accumulation$2.07+0.0%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bullish. Over the past year the shares are up 53%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (8 analysts) rates it hold, with a mean price target of $2.
2026-10-21Accumulation$2.07+0.0%Entry 7
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bullish. Over the past year the shares are up 53%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (8 analysts) rates it hold, with a mean price target of $2.
2026-10-02Accumulation$2.07+0.0%Entry 6
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Over the past year the shares are up 53%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (8 analysts) rates it hold, with a mean price target of $2.
2026-09-08Accumulation$2.07+0.0%Entry 5
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Over the past year the shares are up 53%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (8 analysts) rates it hold, with a mean price target of $2.
2026-08-07Accumulation$2.07+1.5%Entry 4
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Over the past year the shares are up 53%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (8 analysts) rates it hold, with a mean price target of $2.
2026-07-18Accumulation$2.04+0.0%Entry 3
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Over the past year the shares are up 53%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (8 analysts) rates it hold, with a mean price target of $2.
2026-07-03Accumulation$2.04+0.0%Entry 2
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Accumulation$2.04Entry 1
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
